Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-159.1%
operating margin TTM
-125.93%
revenue TTM
19.79 Million
revenue per share TTM
0.65$
valuation ratios | |
|---|---|
| pe ratio | -3.60 |
| peg ratio | -0.27 |
| price to book ratio | 7.37 |
| price to sales ratio | 6.18 |
| enterprise value multiple | -7.24 |
| price fair value | 7.37 |
profitability ratios | |
|---|---|
| gross profit margin | 98.03% |
| operating profit margin | -125.93% |
| pretax profit margin | -159.1% |
| net profit margin | -159.1% |
| return on assets | -30.02% |
| return on equity | -272.87% |
| return on capital employed | -26.22% |
liquidity ratio | |
|---|---|
| current ratio | 9.51 |
| quick ratio | 9.51 |
| cash ratio | 2.71 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 163.01 |
| days of payables outstanding | 813.32 |
| cash conversion cycle | -650.32 |
| receivables turnover | 2.24 |
| payables turnover | 0.45 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.23 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.18 |
| interest coverage | -2.29 |
| cash flow to debt ratio | -8.44 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.78 |
| cash per share | 13.58 |
| operating cash flow per share | -4.77 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -8.44 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -378.04 |
Frequently Asked Questions
When was the last time AnaptysBio, Inc. (NASDAQ:ANAB) reported earnings?
AnaptysBio, Inc. (ANAB) published its most recent earnings results on 05-11-2024.
What is AnaptysBio, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. AnaptysBio, Inc. (NASDAQ:ANAB)'s trailing twelve months ROE is -272.87%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. AnaptysBio, Inc. (ANAB) currently has a ROA of -30.02%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ANAB's net profit margin stand at?
ANAB reported a profit margin of -159.1% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ANAB's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 9.51 in the most recent quarter. The quick ratio stood at 9.51, with a Debt/Eq ratio of 0.23.